{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 48100, "items": [{"indexed": {"date-parts": [[2019, 11, 25]], "date-time": "2019-11-25T23:00:57Z", "timestamp": 1574722857556}, "reference-count": 97, "publisher": "Elsevier BV", "issue": "4", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2017, 4, 1]], "date-time": "2017-04-01T00:00:00Z", "timestamp": 1491004800000}, "delay-in-days": 0, "content-version": "tdm"}], "funder": [{"name": "National Center for Advancing Translational Sciences of the US National Institutes of Health", "award": ["award number UL1TR000454"]}], "content-domain": {"domain": ["clinicalkey.jp", "clinicalkey.com", "clinicalkey.es", "clinicalkey.fr", "clinicalkey.com.au", "thelancet.com", "elsevier.com", "sciencedirect.com"], "crossmark-restriction": true}, "short-container-title": ["The Lancet Diabetes & Endocrinology"], "published-print": {"date-parts": [[2017, 4]]}, "DOI": "10.1016/s2213-8587(16)30319-9", "type": "journal-article", "created": {"date-parts": [[2016, 12, 2]], "date-time": "2016-12-02T01:46:16Z", "timestamp": 1480643176000}, "page": "291-300", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "source": "Crossref", "is-referenced-by-count": 26, "title": ["Oestrogen and anti-androgen therapy for transgender women"], "prefix": "10.1016", "volume": "5", "author": [{"given": "Vin", "family": "Tangpricha", "sequence": "first", "affiliation": []}, {"given": "Martin", "family": "den Heijer", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["The Lancet Diabetes & Endocrinology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S2213858716303199?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S2213858716303199?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 9, 16]], "date-time": "2019-09-16T05:37:38Z", "timestamp": 1568612258000}, "score": 53.41088, "issued": {"date-parts": [[2017, 4]]}, "references-count": 97, "journal-issue": {"published-print": {"date-parts": [[2017, 4]]}, "issue": "4"}, "alternative-id": ["S2213858716303199"], "URL": "http://dx.doi.org/10.1016/s2213-8587(16)30319-9", "ISSN": ["2213-8587"], "issn-type": [{"value": "2213-8587", "type": "print"}], "assertion": [{"value": "Elsevier", "name": "publisher", "label": "This article is maintained by"}, {"value": "Oestrogen and anti-androgen therapy for transgender women", "name": "articletitle", "label": "Article Title"}, {"value": "The Lancet Diabetes & Endocrinology", "name": "journaltitle", "label": "Journal Title"}, {"value": "https://doi.org/10.1016/S2213-8587(16)30319-9", "name": "articlelink", "label": "CrossRef DOI link to publisher maintained version"}, {"value": "https://doi.org/10.1016/S2213-8587(17)30068-2", "name": "associatedlink", "label": "CrossRef DOI link to the associated document"}, {"value": "article", "name": "content_type", "label": "Content Type"}, {"value": "\u00a9 2016 Elsevier Ltd. All rights reserved.", "name": "copyright", "label": "Copyright"}]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T00:48:44Z", "timestamp": 1574729324345}, "reference-count": 8, "publisher": "Elsevier BV", "issue": "4", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2015, 12, 1]], "date-time": "2015-12-01T00:00:00Z", "timestamp": 1448928000000}, "delay-in-days": 0, "content-version": "tdm"}, {"URL": "http://creativecommons.org/licenses/by-nc-nd/4.0/", "start": {"date-parts": [[2015, 9, 16]], "date-time": "2015-09-16T00:00:00Z", "timestamp": 1442361600000}, "delay-in-days": 0, "content-version": "vor"}], "content-domain": {"domain": ["clinicalkey.jp", "jctejournal.com", "clinicalkey.com", "clinicalkey.es", "clinicalkey.fr", "clinicalkey.com.au", "elsevier.com", "sciencedirect.com"], "crossmark-restriction": true}, "short-container-title": ["Journal of Clinical & Translational Endocrinology"], "published-print": {"date-parts": [[2015, 12]]}, "DOI": "10.1016/j.jcte.2015.09.001", "type": "journal-article", "created": {"date-parts": [[2015, 9, 21]], "date-time": "2015-09-21T13:04:44Z", "timestamp": 1442840684000}, "page": "130", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "source": "Crossref", "is-referenced-by-count": 2, "title": ["Safety of transgender hormone therapy"], "prefix": "10.1016", "volume": "2", "author": [{"given": "Vin", "family": "Tangpricha", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Journal of Clinical & Translational Endocrinology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S2214623715000630?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S2214623715000630?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 9, 19]], "date-time": "2018-09-19T08:26:14Z", "timestamp": 1537345574000}, "score": 32.38662, "issued": {"date-parts": [[2015, 12]]}, "references-count": 8, "journal-issue": {"published-print": {"date-parts": [[2015, 12]]}, "issue": "4"}, "alternative-id": ["S2214623715000630"], "URL": "http://dx.doi.org/10.1016/j.jcte.2015.09.001", "ISSN": ["2214-6237"], "issn-type": [{"value": "2214-6237", "type": "print"}], "assertion": [{"value": "Elsevier", "name": "publisher", "label": "This article is maintained by"}, {"value": "Safety of transgender hormone therapy", "name": "articletitle", "label": "Article Title"}, {"value": "Journal of Clinical & Translational Endocrinology", "name": "journaltitle", "label": "Journal Title"}, {"value": "https://doi.org/10.1016/j.jcte.2015.09.001", "name": "articlelink", "label": "CrossRef DOI link to publisher maintained version"}, {"value": "simple-article", "name": "content_type", "label": "Content Type"}, {"name": "copyright", "label": "Copyright"}]}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T18:57:55Z", "timestamp": 1574881075916}, "reference-count": 15, "publisher": "Springer Science and Business Media LLC", "issue": "3", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2018, 9, 1]], "date-time": "2018-09-01T00:00:00Z", "timestamp": 1535760000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": ["link.springer.com"], "crossmark-restriction": false}, "short-container-title": ["Rev Endocr Metab Disord"], "published-print": {"date-parts": [[2018, 9]]}, "DOI": "10.1007/s11154-018-9468-x", "type": "journal-article", "created": {"date-parts": [[2018, 9, 25]], "date-time": "2018-09-25T03:36:18Z", "timestamp": 1537846578000}, "page": "197-198", "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Emerging topics in transgender medicine"], "prefix": "10.1007", "volume": "19", "author": [{"given": "Vin", "family": "Tangpricha", "sequence": "first", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2018, 9, 25]]}, "reference": [{"issue": "11", "key": "9468_CR1", "doi-asserted-by": "publisher", "first-page": "3869", "DOI": "10.1210/jc.2017-01658", "volume": "102", "author": "WC Hembree", "year": "2017", "unstructured": "Hembree WC, Cohen-Kettenis PT, Gooren L, Hannema SE, Meyer WJ, Murad MH, et al. Endocrine treatment of gender-dysphoric/gender-incongruent persons: an Endocrine Society Clinical practice guideline. J Clin Endocrinol Metab. 2017;102(11):3869\u2013903.", "journal-title": "J Clin Endocrinol Metab"}, {"issue": "12", "key": "9468_CR2", "doi-asserted-by": "publisher", "first-page": "1430", "DOI": "10.4158/GL-2017-0115", "volume": "23", "author": "V Tangpricha", "year": "2017", "unstructured": "Tangpricha V, Hannema SE, Irwig MS, Meyer WJ 3rd, Safer JD, Hembree WC. 2017 American association of clinical endocrinologists/endocrine society update on transgender medicine: case discussions. Endocr Pract. 2017;23(12):1430\u20136.", "journal-title": "Endocr Pract"}, {"issue": "4", "key": "9468_CR3", "doi-asserted-by": "publisher", "first-page": "165", "DOI": "10.1080/15532739.2011.700873", "volume": "13", "author": "E Coleman", "year": "2012", "unstructured": "Coleman E, Bockting W, Botzer M, Cohen-Kettenis P, DeCuypere G, Feldman J, et al. Standards of care for the health of transsexual, transgender, and gender-nonconforming people, version 7. International Journal of Transgenderism. 2012;13(4):165\u2013232. \n                    https://doi.org/10.1080/15532739.2011.700873\n                    \n                  .", "journal-title": "International Journal of Transgenderism"}, {"key": "9468_CR4", "unstructured": "Herman JL, Flores AR, Brown TNT, Wilson BDM, Conron KJ. Age of individuals who identify as transgender in the United States. The Williams Institute. UCLA School of law. 2017."}, {"key": "9468_CR5", "unstructured": "Nobili A, Glazebrook C, Arcelus J. Quality of life of treatment-seeking transgender adults: a systematic review and meta-analysis. Rev Endocr Metab Disord. 2018. \n                    https://doi.org/10.1007/s11154-018-9459-y\n                    \n                  .", "DOI": "10.1007/s11154-018-9459-y", "doi-asserted-by": "publisher"}, {"issue": "5", "key": "9468_CR6", "doi-asserted-by": "publisher", "first-page": "e20173845", "DOI": "10.1542/peds.2017-3845", "volume": "141", "author": "Tracy A. Becerra-Culqui", "year": "2018", "unstructured": "Becerra-Culqui TA, Liu Y, Nash R, Cromwell L, Flanders WD, Getahun D, et al. Mental health of transgender and gender nonconforming youth compared with their peers. Pediatrics. 2018;141(5). \n                    https://doi.org/10.1542/peds.2017-3845\n                    \n                  .", "journal-title": "Pediatrics"}, {"issue": "4", "key": "9468_CR7", "doi-asserted-by": "publisher", "first-page": "475", "DOI": "10.1097/MOP.0000000000000516", "volume": "29", "author": "X Lopez", "year": "2017", "unstructured": "Lopez X, Marinkovic M, Eimicke T, Rosenthal SM, Olshan JS, Pediatric Endocrine Society Transgender Health Special Interest Group. Statement on gender-affirmative approach to care from the pediatric endocrine society special interest group on transgender health. Curr Opin Pediatr. 2017;29(4):475\u201380. \n                    https://doi.org/10.1097/MOP.0000000000000516\n                    \n                  .", "journal-title": "Curr Opin Pediatr"}, {"key": "9468_CR8", "unstructured": "Panagiotakopoulos L. Transgender medicine - puberty suppression. Rev Endocr Metab Disord. 2018. \n                    https://doi.org/10.1007/s11154-018-9457-0\n                    \n                  .", "DOI": "10.1007/s11154-018-9457-0", "doi-asserted-by": "publisher"}, {"key": "9468_CR9", "unstructured": "Abramowitz J. Transgender medicine- transitioning transgender children to adulthood. Rev Endocr Metab Disord. 2018. \n                    https://doi.org/10.1007/s11154-018-9458-z\n                    \n                  .", "DOI": "10.1007/s11154-018-9458-z", "doi-asserted-by": "publisher"}, {"key": "9468_CR10", "unstructured": "Mattawanon N, Spencer JB, Schirmer DA 3rd, Tangpricha V. Fertility preservation options in transgender people: a review. Rev Endocr Metab Disord. 2018. \n                    https://doi.org/10.1007/s11154-018-9462-3\n                    \n                  .", "DOI": "10.1007/s11154-018-9462-3", "doi-asserted-by": "publisher"}, {"key": "9468_CR11", "unstructured": "Irwig MS. Cardiovascular health in transgender people. Rev Endocr Metab Disord. 2018. \n                    https://doi.org/10.1007/s11154-018-9454-3\n                    \n                  .", "DOI": "10.1007/s11154-018-9454-3", "doi-asserted-by": "publisher"}, {"key": "9468_CR12", "unstructured": "Gooren LJ, T'Sjoen G. Endocrine treatment of aging transgender people. Rev Endocr Metab Disord. 2018. \n                    https://doi.org/10.1007/s11154-018-9449-0\n                    \n                  .", "DOI": "10.1007/s11154-018-9449-0", "doi-asserted-by": "publisher"}, {"issue": "4", "key": "9468_CR13", "doi-asserted-by": "publisher", "first-page": "205", "DOI": "10.7326/M17-2785", "volume": "169", "author": "D Getahun", "year": "2018", "unstructured": "Getahun D, Nash R, Flanders WD, Baird TC, Becerra-Culqui TA, Cromwell L, et al. Cross-sex hormones and acute cardiovascular events in transgender persons: a cohort study. Ann Intern Med. 2018;169(4):205\u201313. \n                    https://doi.org/10.7326/M17-2785\n                    \n                  .", "journal-title": "Ann Intern Med"}, {"key": "9468_CR14", "unstructured": "Gerth J, Becerra-Culqui T, Bradlyn A, Getahun D, Hunkeler EM, Lash TL, et al. Agreement between medical records and self-reports: implications for transgender health research. Rev Endocr Metab Disord. 2018. \n                    https://doi.org/10.1007/s11154-018-9461-4\n                    \n                  .", "DOI": "10.1007/s11154-018-9461-4", "doi-asserted-by": "publisher"}, {"key": "9468_CR15", "unstructured": "Korpaisarn S, Safer JD. Gaps in transgender medical education among healthcare providers: a major barrier to care for transgender persons. Rev Endocr Metab Disord. 2018. \n                    https://doi.org/10.1007/s11154-018-9452-5\n                    \n                  .", "DOI": "10.1007/s11154-018-9452-5", "doi-asserted-by": "publisher"}], "container-title": ["Reviews in Endocrine and Metabolic Disorders"], "language": "en", "link": [{"URL": "http://link.springer.com/article/10.1007/s11154-018-9468-x/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s11154-018-9468-x.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s11154-018-9468-x.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 9, 25]], "date-time": "2019-09-25T07:28:09Z", "timestamp": 1569396489000}, "score": 27.458538, "issued": {"date-parts": [[2018, 9]]}, "references-count": 15, "journal-issue": {"published-print": {"date-parts": [[2018, 9]]}, "issue": "3"}, "alternative-id": ["9468"], "URL": "http://dx.doi.org/10.1007/s11154-018-9468-x", "relation": {"cites": []}, "ISSN": ["1389-9155", "1573-2606"], "issn-type": [{"value": "1389-9155", "type": "print"}, {"value": "1573-2606", "type": "electronic"}], "assertion": [{"value": "25 September 2018", "order": 1, "name": "first_online", "label": "First Online", "group": {"name": "ArticleHistory", "label": "Article History"}}, {"order": 1, "name": "Ethics", "group": {"name": "EthicsHeading", "label": "Compliance with ethical standards"}}, {"value": "Dr. Tangpricha receives grant funding from the Cystic Fibrosis Foundation and the National Institutes of Health. He has no other financial conflicts of interest to disclose.", "order": 2, "name": "Ethics", "group": {"name": "EthicsHeading", "label": "Conflict of interest"}}]}, {"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T06:52:49Z", "timestamp": 1575442369074}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "2", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2019, 6, 1]], "date-time": "2019-06-01T00:00:00Z", "timestamp": 1559347200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Endocrinology and Metabolism Clinics of North America"], "published-print": {"date-parts": [[2019, 6]]}, "DOI": "10.1016/s0889-8529(19)30017-9", "type": "journal-article", "created": {"date-parts": [[2019, 4, 23]], "date-time": "2019-04-23T20:06:30Z", "timestamp": 1556049990000}, "page": "i", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Transgender Medicine"], "prefix": "10.1016", "volume": "48", "author": [{"given": "Vin", "family": "Tangpricha", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Endocrinology and Metabolism Clinics of North America"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0889852919300179?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0889852919300179?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 6, 17]], "date-time": "2019-06-17T14:11:46Z", "timestamp": 1560780706000}, "score": 27.458538, "issued": {"date-parts": [[2019, 6]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2019, 6]]}, "issue": "2"}, "alternative-id": ["S0889852919300179"], "URL": "http://dx.doi.org/10.1016/s0889-8529(19)30017-9", "ISSN": ["0889-8529"], "issn-type": [{"value": "0889-8529", "type": "print"}], "subject": ["Endocrinology, Diabetes and Metabolism", "Endocrinology"]}, {"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T06:52:49Z", "timestamp": 1575442369034}, "reference-count": 4, "publisher": "Elsevier BV", "issue": "2", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2019, 6, 1]], "date-time": "2019-06-01T00:00:00Z", "timestamp": 1559347200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": ["clinicalkey.jp", "clinicalkey.com", "clinicalkey.es", "theclinics.com", "clinicalkey.com.au", "clinicalkey.fr", "elsevier.com", "sciencedirect.com"], "crossmark-restriction": true}, "short-container-title": ["Endocrinology and Metabolism Clinics of North America"], "published-print": {"date-parts": [[2019, 6]]}, "DOI": "10.1016/j.ecl.2019.03.001", "type": "journal-article", "created": {"date-parts": [[2019, 4, 23]], "date-time": "2019-04-23T20:06:17Z", "timestamp": 1556049977000}, "page": "xv-xvii", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Transgender Medicine: Best Practices and Clinical Care for the Future"], "prefix": "10.1016", "volume": "48", "author": [{"given": "Vin", "family": "Tangpricha", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Endocrinology and Metabolism Clinics of North America"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0889852919300143?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0889852919300143?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 6, 17]], "date-time": "2019-06-17T14:11:48Z", "timestamp": 1560780708000}, "score": 26.040533, "issued": {"date-parts": [[2019, 6]]}, "references-count": 4, "journal-issue": {"published-print": {"date-parts": [[2019, 6]]}, "issue": "2"}, "alternative-id": ["S0889852919300143"], "URL": "http://dx.doi.org/10.1016/j.ecl.2019.03.001", "ISSN": ["0889-8529"], "issn-type": [{"value": "0889-8529", "type": "print"}], "subject": ["Endocrinology, Diabetes and Metabolism", "Endocrinology"], "assertion": [{"value": "Elsevier", "name": "publisher", "label": "This article is maintained by"}, {"value": "Transgender Medicine: Best Practices and Clinical Care for the Future", "name": "articletitle", "label": "Article Title"}, {"value": "Endocrinology and Metabolism Clinics of North America", "name": "journaltitle", "label": "Journal Title"}, {"value": "https://doi.org/10.1016/j.ecl.2019.03.001", "name": "articlelink", "label": "CrossRef DOI link to publisher maintained version"}, {"value": "simple-article", "name": "content_type", "label": "Content Type"}, {"value": "\u00a9 2019 Published by Elsevier Inc.", "name": "copyright", "label": "Copyright"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T09:31:48Z", "timestamp": 1574415108615}, "publisher-location": "Berlin, Heidelberg", "reference-count": 15, "publisher": "Springer Berlin Heidelberg", "isbn-type": [{"value": "9783642715082", "type": "print"}, {"value": "9783642715068", "type": "electronic"}], "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[1986, 1, 1]], "date-time": "1986-01-01T00:00:00Z", "timestamp": 504921600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[1986]]}, "DOI": "10.1007/978-3-642-71506-8_4", "type": "book-chapter", "created": {"date-parts": [[2011, 11, 4]], "date-time": "2011-11-04T04:15:53Z", "timestamp": 1320380153000}, "page": "41-49", "source": "Crossref", "is-referenced-by-count": 2, "title": ["Oestrogen and Anti-Oestrogen Action: A Hypothesis for the Regulation of Breast Cancer Cell Replication"], "prefix": "10.1007", "author": [{"given": "V. C.", "family": "Jordan", "sequence": "first", "affiliation": []}], "member": "297", "reference": [{"key": "4_CR1", "first-page": "412", "volume": "8", "author": "A Cantarow", "year": "1984", "unstructured": "Cantarow A, Stasney J and Paschis KE: The influence of sex hormones on mammary tumors induced by 2-acetaminofluorene. Cancer Res 1984 (8): 412\u2013417", "journal-title": "Cancer Res"}, {"key": "4_CR2", "first-page": "3448", "volume": "44", "author": "SL Fitzpatrick", "year": "1984", "unstructured": "Fitzpatrick SL, Brightwell J, Wittliff JL, Barrow GH and Schultz GS: Epidermal growth factor binding by breast tumor biopsies and relationship to estrogen and progestin receptor levels. Cancer Res 1984 (44): 3448\u20133453", "journal-title": "Cancer Res"}, {"key": "4_CR3", "first-page": "3342", "volume": "44", "author": "SL Fitzpatrick", "year": "1984", "unstructured": "Fitzpatrick SL, Lachance MP and Schultz GS: Characterization of epidermal growth factor receptor and action on human breast cells in culture. Cancer Res 1984 (44): 3342\u20133447", "journal-title": "Cancer Res"}, {"key": "4_CR4", "doi-asserted-by": "publisher", "first-page": "127", "DOI": "10.1016/0163-7258(84)90043-3", "volume": "25", "author": "BJA Furr", "year": "1984", "unstructured": "Furr BJA and Jordan VC: Pharmacology and clinical uses of tamoxifen. Pharm Therap 1984 (25): 127\u2013205", "journal-title": "Pharm Therap"}, {"key": "4_CR5", "first-page": "2223", "volume": "253", "author": "KB Horwitz", "year": "1978", "unstructured": "Horwitz KB and McGuire WL: Estrogen control of progesterone receptor in human breast cancer. J Biol Chem 1978 (253): 2223\u20132228", "journal-title": "J Biol Chem"}, {"key": "4_CR6", "doi-asserted-by": "publisher", "first-page": "1742", "DOI": "10.1210/endo-103-5-1742", "volume": "103", "author": "KB Horwitz", "year": "1978", "unstructured": "Horwitz KB, Koseki Y and McGuire WL: Estrogen of progesterone receptor in human breast cancer: role of estradiol and antiestrogen. Endocrinology 1978 (103): 1742\u20131751", "journal-title": "Endocrinology"}, {"key": "4_CR7", "doi-asserted-by": "publisher", "first-page": "257", "DOI": "10.1126/science.137.3526.257", "volume": "137", "author": "C Huggins", "year": "1962", "unstructured": "Huggins C and Young NC: Induction and extinction of mammary cancer. Science 1962 (137): 257\u2013262", "journal-title": "Science"}, {"key": "4_CR8", "doi-asserted-by": "publisher", "first-page": "2795", "DOI": "10.1016/0006-2952(85)90581-7", "volume": "34", "author": "SD Lyman", "year": "1985", "unstructured": "Lyman SD and Jordan VC: Possible mechanisms for the agonist actions of tamoxifen and the antagonist actions of MER-2 (ethamoxytriphetol) in the mouse uterus. Biochem Pharm 1985 (34): 2795\u20132806", "journal-title": "Biochem Pharm"}, {"key": "4_CR9", "first-page": "728", "volume": "460", "author": "LJ Murphy", "year": "1986", "unstructured": "Murphy LJ, Sutherland, Stead B, Myrphy LC and Lazarus L: Progestin regulations of epidermal growth factor receptor in human mammary carcinoma cells. Cancer Res 1986 (460): 728\u2013734", "journal-title": "Cancer Res"}, {"key": "4_CR10", "doi-asserted-by": "publisher", "first-page": "86", "DOI": "10.1210/jcem-55-1-86", "volume": "55", "author": "CK Osborne", "year": "1982", "unstructured": "Osborne CK, Hamilton B, Titus G and Livingston RB: Receptor binding and processing of epidermal growth factor by human breast cancer cells. J Clin Endocr Metab 1982 (55): 86\u201393", "journal-title": "J Clin Endocr Metab"}, {"key": "4_CR11", "doi-asserted-by": "publisher", "first-page": "57", "DOI": "10.1007/BF01806011", "volume": "6", "author": "PM Ravdin", "year": "1985", "unstructured": "Ravdin PM, Welshons WV and Jordan VC: Regulation of estrogen receptor (ER) levels in human breast cancer cell lines by epidermal growth factor (EGF). Breast Cancer Res Treat 6: Abstract 1985 (57)", "journal-title": "Breast Cancer Res Treat"}, {"key": "4_CR12", "author": "SP Robinson", "year": "1986", "unstructured": "Robinson SP and Jordan VC: Opposing actions of progesterone and tamoxifen in rats with dimethylbenzathracene (DMBA)- induced rat mammary tumors. Proceedings of the Endocrine Society Anaheim CA 1986.", "volume-title": "Opposing actions of progesterone and tamoxifen in rats with dimethylbenzathracene (DMBA)- induced rat mammary tumors"}, {"key": "4_CR13", "doi-asserted-by": "publisher", "first-page": "184", "DOI": "10.1016/0305-7372(84)90008-2", "volume": "11", "author": "RC Stuart-Harris", "year": "1984", "unstructured": "Stuart-Harris RC and Smith IE: Aminoglutethimide in the treatment of advanced breast cancer. Cancer Treat Rev 1984 (11): 184\u2013204", "journal-title": "Cancer Treat Rev"}, {"key": "4_CR14", "doi-asserted-by": "publisher", "first-page": "273", "DOI": "10.1038/288273a0", "volume": "288", "author": "RL Sutherland", "year": "1980", "unstructured": "Sutherland RL, Murphy LC, Foo MS, Green MD, Whybourne AM and Krozowski ZS: High affinity antioestrogen binding site distinct from the oestrogen receptor. Nature (London) 1980 (288): 273\u2013275", "journal-title": "Nature (London)"}, {"key": "4_CR15", "doi-asserted-by": "publisher", "first-page": "297", "DOI": "10.1007/BF01806042", "volume": "4", "author": "DC Tormey", "year": "1984", "unstructured": "Tormey DC and Jordan VC: Long-term adjuvant therapy in node positive breast cancer - a metabolic and pilot clinical study. Breast Cancer Res Treat 1984 (4): 297\u2013302", "journal-title": "Breast Cancer Res Treat"}], "container-title": ["Endocrine Therapy of Breast Cancer"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-3-642-71506-8_4", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 15]], "date-time": "2019-05-15T06:48:16Z", "timestamp": 1557902896000}, "score": 26.02333, "issued": {"date-parts": [[1986]]}, "ISBN": ["9783642715082", "9783642715068"], "references-count": 15, "URL": "http://dx.doi.org/10.1007/978-3-642-71506-8_4", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T14:12:15Z", "timestamp": 1575468735964}, "reference-count": 55, "publisher": "American College of Physicians", "issue": "1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Ann Intern Med"], "published-print": {"date-parts": [[2019, 7, 2]]}, "DOI": "10.7326/aitc201907020", "type": "journal-article", "created": {"date-parts": [[2019, 7, 1]], "date-time": "2019-07-01T21:30:34Z", "timestamp": 1562016634000}, "page": "ITC1", "source": "Crossref", "is-referenced-by-count": 7, "title": ["Care of the Transgender Patient"], "prefix": "10.7326", "volume": "171", "author": [{"given": "Joshua D.", "family": "Safer", "sequence": "first", "affiliation": [{"name": "Mount Sinai Health System and Icahn School of Medicine at Mount Sinai, New York, New York (J.D.S.)"}]}, {"given": "Vin", "family": "Tangpricha", "sequence": "additional", "affiliation": [{"name": "Emory University School of Medicine and Atlanta VA Medical Center, Atlanta, Georgia (V.T.)"}]}], "member": "4285", "container-title": ["Annals of Internal Medicine"], "language": "en", "link": [{"URL": "https://annals.org/aim/fullarticle/2737401/care-transgender-patient", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 7, 1]], "date-time": "2019-07-01T21:30:38Z", "timestamp": 1562016638000}, "score": 24.640556, "issued": {"date-parts": [[2019, 7, 2]]}, "references-count": 55, "journal-issue": {"published-print": {"date-parts": [[2019, 7, 2]]}, "issue": "1"}, "URL": "http://dx.doi.org/10.7326/aitc201907020", "ISSN": ["0003-4819"], "issn-type": [{"value": "0003-4819", "type": "print"}], "subject": ["Internal Medicine", "General Medicine"]}, {"indexed": {"date-parts": [[2019, 12, 5]], "date-time": "2019-12-05T12:54:51Z", "timestamp": 1575550491460}, "reference-count": 0, "publisher": "American College of Physicians", "issue": "10", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Ann Intern Med"], "published-print": {"date-parts": [[2019, 11, 19]]}, "DOI": "10.7326/l19-0535", "type": "journal-article", "created": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T23:31:55Z", "timestamp": 1574119915000}, "page": "775", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Care of the Transgender Patient"], "prefix": "10.7326", "volume": "171", "author": [{"given": "Joshua D.", "family": "Safer", "sequence": "first", "affiliation": [{"name": "Mount Sinai Health System and Icahn School of Medicine at Mount Sinai, New York, New York (J.D.S.)"}]}, {"given": "Vin", "family": "Tangpricha", "sequence": "additional", "affiliation": [{"name": "Emory University School of Medicine and Atlanta VA Medical Center, Atlanta, Georgia (V.T.)"}]}], "member": "4285", "container-title": ["Annals of Internal Medicine"], "language": "en", "link": [{"URL": "https://annals.org/aim/fullarticle/2755702/care-transgender-patient", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T23:32:19Z", "timestamp": 1574119939000}, "score": 24.640556, "issued": {"date-parts": [[2019, 11, 19]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2019, 11, 19]]}, "issue": "10"}, "URL": "http://dx.doi.org/10.7326/l19-0535", "ISSN": ["0003-4819"], "issn-type": [{"value": "0003-4819", "type": "print"}], "subject": ["Internal Medicine", "General Medicine"]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T13:17:24Z", "timestamp": 1575206244571}, "reference-count": 10, "publisher": "AACE Corp (American Association of Clinical Endocrinologists)", "issue": "2", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Endocrine Practice"], "published-print": {"date-parts": [[2008, 3]]}, "DOI": "10.4158/ep.14.2.248", "type": "journal-article", "created": {"date-parts": [[2013, 4, 6]], "date-time": "2013-04-06T02:07:48Z", "timestamp": 1365214068000}, "page": "248-250", "source": "Crossref", "is-referenced-by-count": 23, "title": ["Out of the Shadows: It is Time to Mainstream Treatment for Transgender Patients"], "prefix": "10.4158", "volume": "14", "author": [{"given": "Joshua", "family": "Safer", "sequence": "first", "affiliation": []}, {"given": "Vin", "family": "Tangpricha", "sequence": "additional", "affiliation": []}], "member": "2653", "container-title": ["Endocrine Practice"], "language": "en", "link": [{"URL": "http://aace.metapress.com/index/NM510264636815VK.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 7, 11]], "date-time": "2019-07-11T23:57:07Z", "timestamp": 1562889427000}, "score": 24.396461, "issued": {"date-parts": [[2008, 3]]}, "references-count": 10, "journal-issue": {"published-print": {"date-parts": [[2008, 3]]}, "issue": "2"}, "alternative-id": ["10.4158/EP.14.2.248"], "URL": "http://dx.doi.org/10.4158/ep.14.2.248", "ISSN": ["1530-891X", "1934-2403"], "issn-type": [{"value": "1530-891X", "type": "print"}, {"value": "1934-2403", "type": "electronic"}], "subject": ["Endocrinology, Diabetes and Metabolism", "Endocrinology", "General Medicine"]}, {"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T01:42:20Z", "timestamp": 1575423740144}, "reference-count": 39, "publisher": "Elsevier BV", "issue": "2", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2019, 6, 1]], "date-time": "2019-06-01T00:00:00Z", "timestamp": 1559347200000}, "delay-in-days": 0, "content-version": "tdm"}], "funder": [{"DOI": "10.13039/100006108", "name": "National Center for Advancing Translational Sciences", "doi-asserted-by": "publisher", "award": ["UL1TR002378"]}], "content-domain": {"domain": ["clinicalkey.jp", "clinicalkey.com", "clinicalkey.es", "theclinics.com", "clinicalkey.com.au", "clinicalkey.fr", "elsevier.com", "sciencedirect.com"], "crossmark-restriction": true}, "short-container-title": ["Endocrinology and Metabolism Clinics of North America"], "published-print": {"date-parts": [[2019, 6]]}, "DOI": "10.1016/j.ecl.2019.02.006", "type": "journal-article", "created": {"date-parts": [[2019, 3, 23]], "date-time": "2019-03-23T07:24:59Z", "timestamp": 1553325899000}, "page": "421-427", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "source": "Crossref", "is-referenced-by-count": 2, "title": ["Osteoporosis and Bone Health in Transgender Persons"], "prefix": "10.1016", "volume": "48", "author": [{"given": "Mary O.", "family": "Stevenson", "sequence": "first", "affiliation": []}, {"given": "Vin", "family": "Tangpricha", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Endocrinology and Metabolism Clinics of North America"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0889852919300118?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0889852919300118?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 8, 7]], "date-time": "2019-08-07T09:40:36Z", "timestamp": 1565170836000}, "score": 23.222551, "issued": {"date-parts": [[2019, 6]]}, "references-count": 39, "journal-issue": {"published-print": {"date-parts": [[2019, 6]]}, "issue": "2"}, "alternative-id": ["S0889852919300118"], "URL": "http://dx.doi.org/10.1016/j.ecl.2019.02.006", "ISSN": ["0889-8529"], "issn-type": [{"value": "0889-8529", "type": "print"}], "subject": ["Endocrinology, Diabetes and Metabolism", "Endocrinology"], "assertion": [{"value": "Elsevier", "name": "publisher", "label": "This article is maintained by"}, {"value": "Osteoporosis and Bone Health in Transgender Persons", "name": "articletitle", "label": "Article Title"}, {"value": "Endocrinology and Metabolism Clinics of North America", "name": "journaltitle", "label": "Journal Title"}, {"value": "https://doi.org/10.1016/j.ecl.2019.02.006", "name": "articlelink", "label": "CrossRef DOI link to publisher maintained version"}, {"value": "article", "name": "content_type", "label": "Content Type"}, {"value": "\u00a9 2019 Elsevier Inc. All rights reserved.", "name": "copyright", "label": "Copyright"}]}, {"indexed": {"date-parts": [[2019, 12, 16]], "date-time": "2019-12-16T22:40:48Z", "timestamp": 1576536048152}, "reference-count": 17, "publisher": "Springer Science and Business Media LLC", "issue": "3", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2018, 9, 1]], "date-time": "2018-09-01T00:00:00Z", "timestamp": 1535760000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": ["link.springer.com"], "crossmark-restriction": false}, "short-container-title": ["Rev Endocr Metab Disord"], "published-print": {"date-parts": [[2018, 9]]}, "DOI": "10.1007/s11154-018-9471-2", "type": "journal-article", "created": {"date-parts": [[2018, 10, 31]], "date-time": "2018-10-31T07:39:07Z", "timestamp": 1540971547000}, "page": "193-195", "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Gender dysphoria and transgender medicine in the year 2018"], "prefix": "10.1007", "volume": "19", "author": [{"given": "Christian A.", "family": "Koch", "sequence": "first", "affiliation": []}, {"given": "Vin", "family": "Tangpricha", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2018, 10, 31]]}, "reference": [{"key": "9471_CR1", "unstructured": "Tangpricha V. Emerging topics in transgender medicine. Rev Endocr Metab Disord. 2018. \n                    https://doi.org/10.1007/s11154-018-9468-x\n                    \n                  .", "DOI": "10.1007/s11154-018-9468-x", "doi-asserted-by": "publisher"}, {"issue": "11", "key": "9471_CR2", "doi-asserted-by": "publisher", "first-page": "3869", "DOI": "10.1210/jc.2017-01658", "volume": "102", "author": "WC Hembree", "year": "2017", "unstructured": "Hembree WC, Cohen-Kettenis PT, Gooren L, Hannema SE, Meyer WJ, Murad MH, et al. Endocrine treatment of gender-dysphoric/ gender-incongruent persons: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2017;102(11):3869\u2013903.", "journal-title": "J Clin Endocrinol Metab"}, {"issue": "12", "key": "9471_CR3", "doi-asserted-by": "publisher", "first-page": "1430", "DOI": "10.4158/GL-2017-0115", "volume": "23", "author": "Vin Tangpricha", "year": "2017", "unstructured": "Tangpricha V, Hannema SE, Irwig MS, Meyer WJ 3rd, Safer JD, Hembree WC. 2017 American association of clinical endocrinologists/endocrine society update on transgender medicine: case discussions. Endocr Pract 2017;23(12):1430\u20131436.", "journal-title": "Endocrine Practice"}, {"issue": "5", "key": "9471_CR4", "doi-asserted-by": "publisher", "first-page": "1479", "DOI": "10.1111/j.1743-6109.2007.00556.x", "volume": "4", "author": "JW Jacobeit", "year": "2007", "unstructured": "Jacobeit JW, Gooren LJ, Schulte HM. Long-acting intramuscular testosterone undecanoate for treatment of female-to-male transgender individuals. J Sex Med. 2007;4(5):1479\u201384.", "journal-title": "J Sex Med"}, {"issue": "11", "key": "9471_CR5", "doi-asserted-by": "publisher", "first-page": "2190", "DOI": "10.1111/jsm.13022", "volume": "12", "author": "F Schneider", "year": "2015", "unstructured": "Schneider F, Neuhaus N, Wistuba J, Zitzmann M, He\u00df J, Mahler D, et al. Testicular Functions and Clinical Characterization of Patients with Gender Dysphoria (GD) Undergoing Sex Reassignment Surgery (SRS). J Sex Med. 2015 Nov;12(11):2190\u2013200.", "journal-title": "J Sex Med"}, {"issue": "3", "key": "9471_CR6", "doi-asserted-by": "publisher", "first-page": "175", "DOI": "10.1007/s11154-015-9324-1", "volume": "16", "author": "Christian A. Koch", "year": "2015", "unstructured": "Koch CA, Zitzmann M. Introduction to endocrinological aspects of andrology-what is new? Rev Endocr Metab Disord. 2015;16(3):175", "journal-title": "Reviews in Endocrine and Metabolic Disorders"}, {"key": "9471_CR7", "unstructured": "Nobili A, Glazebrook C, Arcelus J. Quality of life of treatmentseeking transgender adults: a systematic review and meta-analysis. Rev Endocr Metab Disord. 2018. \n                    https://doi.org/10.1007/s11154-018-9459-y\n                    \n                  .", "DOI": "10.1007/s11154-018-9459-y", "doi-asserted-by": "publisher"}, {"key": "9471_CR8", "unstructured": "Panagiotakopoulos L. Transgender medicine - puberty suppression. Rev Endocr Metab Disord. 2018. \n                    https://doi.org/10.1007/s11154-018-9457-0\n                    \n                  .", "DOI": "10.1007/s11154-018-9457-0", "doi-asserted-by": "publisher"}, {"key": "9471_CR9", "unstructured": "Abramowitz J. Transgender medicine- transitioning transgender children to adulthood. Rev Endocr Metab Disord. 2018. \n                    https://doi.org/10.1007/s11154-018-9458-z\n                    \n                  .", "DOI": "10.1007/s11154-018-9458-z", "doi-asserted-by": "publisher"}, {"key": "9471_CR10", "unstructured": "Mattawanon N, Spencer JB, Schirmer DA 3rd, Tangpricha V. Fertility preservation options in transgender people: a review. Rev Endocr Metab Disord 2018. \n                    https://doi.org/10.1007/s11154-018-9462-3\n                    \n                  .", "DOI": "10.1007/s11154-018-9462-3", "doi-asserted-by": "publisher"}, {"key": "9471_CR11", "unstructured": "Irwig MS. Cardiovascular health in transgender people. Rev Endocr Metab Disord. 2018. \n                    https://doi.org/10.1007/s11154-018-9454-3\n                    \n                  .", "DOI": "10.1007/s11154-018-9454-3", "doi-asserted-by": "publisher"}, {"key": "9471_CR12", "unstructured": "Gooren LJ, T'Sjoen G. Endocrine treatment of aging transgender people. Rev Endocr Metab Disord. 2018. \n                    https://doi.org/10.1007/s11154-018-9449-0\n                    \n                  .", "DOI": "10.1007/s11154-018-9449-0", "doi-asserted-by": "publisher"}, {"key": "9471_CR13", "unstructured": "Gerth J, Becerra-Culqui T, Bradlyn A, Getahun D, Hunkeler EM, Lash TL, et al. Agreement between medical records and self-reports: implications for transgender health research. Rev Endocr Metab Disord. 2018. \n                    https://doi.org/10.1007/s11154-018-9461-4\n                    \n                  .", "DOI": "10.1007/s11154-018-9461-4", "doi-asserted-by": "publisher"}, {"key": "9471_CR14", "unstructured": "Korpaisarn S, Safer JD. Gaps in transgender medical education among healthcare providers: a major barrier to care for transgender persons. Rev Endocr Metab Disord. 2018. \n                    https://doi.org/10.1007/s11154-018-9452-5\n                    \n                  .", "DOI": "10.1007/s11154-018-9452-5", "doi-asserted-by": "publisher"}, {"issue": "4", "key": "9471_CR15", "doi-asserted-by": "publisher", "first-page": "205", "DOI": "10.7326/M17-2785", "volume": "169", "author": "D Getahun", "year": "2018", "unstructured": "Getahun D, Nash R, Flanders WD, Baird TC, Becerra-Culqui TA, Cromwell L, et al. Cross-sex hormones and acute cardiovascular events in transgender persons: a cohort study. Ann Intern Med. 2018;169(4):205\u201313. \n                    https://doi.org/10.7326/M17-2785\n                    \n                  .", "journal-title": "Ann Intern Med"}, {"issue": "5", "key": "9471_CR16", "doi-asserted-by": "publisher", "first-page": "1396", "DOI": "10.1161/01.ATV.20.5.1396", "volume": "20", "author": "EJ Giltay", "year": "2000", "unstructured": "Giltay EJ, Gooren LJ, Emeis JJ, Kooistra T, Stehouwer CD. Oral, but not transdermal, administration of estrogens lowers tissue-type plasminogen activator levels in humans without affecting endothelial synthesis. Arterioscler Thromb Vasc Biol. 2000;20(5):1396\u2013403.", "journal-title": "Arterioscler Thromb Vasc Biol"}, {"issue": "4", "key": "9471_CR17", "doi-asserted-by": "publisher", "first-page": "1267", "DOI": "10.1016/j.fertnstert.2008.12.017", "volume": "93", "author": "J Ott", "year": "2010", "unstructured": "Ott J, Kaufmann U, Bentz EK, Huber JC, Tempfer CB. Incidence of thrombophilia and venous thrombosis in transsexuals under cross-sex hormone therapy. Fertil Steril. 2010;93(4):1267\u201372.", "journal-title": "Fertil Steril"}], "container-title": ["Reviews in Endocrine and Metabolic Disorders"], "language": "en", "link": [{"URL": "http://link.springer.com/article/10.1007/s11154-018-9471-2/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s11154-018-9471-2.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s11154-018-9471-2.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 12, 16]], "date-time": "2019-12-16T17:19:03Z", "timestamp": 1576516743000}, "score": 23.222551, "issued": {"date-parts": [[2018, 9]]}, "references-count": 17, "journal-issue": {"published-print": {"date-parts": [[2018, 9]]}, "issue": "3"}, "alternative-id": ["9471"], "URL": "http://dx.doi.org/10.1007/s11154-018-9471-2", "relation": {"cites": []}, "ISSN": ["1389-9155", "1573-2606"], "issn-type": [{"value": "1389-9155", "type": "print"}, {"value": "1573-2606", "type": "electronic"}], "subject": ["Endocrinology, Diabetes and Metabolism", "Endocrinology"], "assertion": [{"value": "31 October 2018", "order": 1, "name": "first_online", "label": "First Online", "group": {"name": "ArticleHistory", "label": "Article History"}}, {"order": 1, "name": "Ethics", "group": {"name": "EthicsHeading", "label": "Compliance with ethical standards"}}, {"value": "Prof. Koch declares that he has no conflict of interest related to this article.", "order": 2, "name": "Ethics", "group": {"name": "EthicsHeading", "label": "Conflict of interest"}}]}, {"indexed": {"date-parts": [[2019, 12, 18]], "date-time": "2019-12-18T22:40:22Z", "timestamp": 1576708822774}, "reference-count": 47, "publisher": "Massachusetts Medical Society", "issue": "25", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["N Engl J Med"], "published-print": {"date-parts": [[2019, 12, 19]]}, "DOI": "10.1056/nejmcp1903650", "type": "journal-article", "created": {"date-parts": [[2019, 12, 18]], "date-time": "2019-12-18T22:01:24Z", "timestamp": 1576706484000}, "page": "2451-2460", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Care of Transgender Persons"], "prefix": "10.1056", "volume": "381", "author": [{"given": "Joshua D.", "family": "Safer", "sequence": "first", "affiliation": [{"name": "From the Center for Transgender Medicine and Surgery, Mount Sinai Health System and Icahn School of Medicine at Mount Sinai, New York (J.D.S.); and the Division of Endocrinology, Metabolism, and Lipids, Department of Medicine, Emory University School of Medicine, and the Atlanta Veterans Affairs Medical Center \u2014 both in Atlanta (V.T.)."}]}, {"given": "Vin", "family": "Tangpricha", "sequence": "additional", "affiliation": [{"name": "From the Center for Transgender Medicine and Surgery, Mount Sinai Health System and Icahn School of Medicine at Mount Sinai, New York (J.D.S.); and the Division of Endocrinology, Metabolism, and Lipids, Department of Medicine, Emory University School of Medicine, and the Atlanta Veterans Affairs Medical Center \u2014 both in Atlanta (V.T.)."}]}], "member": "150", "container-title": ["New England Journal of Medicine"], "language": "en", "link": [{"URL": "http://www.nejm.org/doi/pdf/10.1056/NEJMcp1903650", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 12, 18]], "date-time": "2019-12-18T22:01:55Z", "timestamp": 1576706515000}, "score": 23.222551, "editor": [{"given": "Caren G.", "family": "Solomon", "sequence": "additional", "affiliation": []}], "issued": {"date-parts": [[2019, 12, 19]]}, "references-count": 47, "journal-issue": {"published-print": {"date-parts": [[2019, 12, 19]]}, "issue": "25"}, "alternative-id": ["10.1056/NEJMcp1903650"], "URL": "http://dx.doi.org/10.1056/nejmcp1903650", "ISSN": ["0028-4793", "1533-4406"], "issn-type": [{"value": "0028-4793", "type": "print"}, {"value": "1533-4406", "type": "electronic"}], "subject": ["General Medicine"]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T09:58:27Z", "timestamp": 1574330307791}, "reference-count": 0, "publisher": "Bioscientifica", "issue": "1_Suppl", "content-domain": {"domain": ["eje.bioscientifica.com"], "crossmark-restriction": true}, "published-print": {"date-parts": [[1969, 8]]}, "DOI": "10.1530/acta.0.061s235", "type": "journal-article", "created": {"date-parts": [[2009, 10, 21]], "date-time": "2009-10-21T22:07:49Z", "timestamp": 1256162869000}, "page": "S235", "update-policy": "http://dx.doi.org/10.1530/crossmarkpolicy-1", "source": "Crossref", "is-referenced-by-count": 0, "title": ["RELATIVE OESTROGEN CONCENTRATIONS IN BREAST TUMOUR TISSUE FOLLOWING ANDROGEN THERAPY"], "prefix": "10.1530", "volume": "61", "author": [{"given": "Hannelore", "family": "Braunsberg", "sequence": "first", "affiliation": []}, {"given": "A. E.", "family": "Carter", "sequence": "additional", "affiliation": []}, {"given": "W. T.", "family": "Irvine", "sequence": "additional", "affiliation": []}, {"given": "V. H. T.", "family": "James", "sequence": "additional", "affiliation": []}], "member": "416", "container-title": ["Acta Endocrinologica"], "link": [{"URL": "https://eje.bioscientifica.com/view/journals/eje/61/1_Suppl/acta_61_Suppl_138_234.xml", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 8, 30]], "date-time": "2018-08-30T20:46:41Z", "timestamp": 1535662001000}, "score": 22.69678, "issued": {"date-parts": [[1969, 8]]}, "references-count": 0, "journal-issue": {"issue": "1_Suppl"}, "URL": "http://dx.doi.org/10.1530/acta.0.061s235", "ISSN": ["0804-4643", "1479-683X"], "issn-type": [{"value": "0804-4643", "type": "print"}, {"value": "1479-683X", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T13:50:35Z", "timestamp": 1575294635657}, "reference-count": 6, "publisher": "Mary Ann Liebert Inc", "issue": "1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Transgender Health"], "published-print": {"date-parts": [[2018, 5]]}, "DOI": "10.1089/trgh.2018.0001", "type": "journal-article", "created": {"date-parts": [[2018, 5, 4]], "date-time": "2018-05-04T18:08:04Z", "timestamp": 1525457284000}, "page": "71-73", "source": "Crossref", "is-referenced-by-count": 2, "title": ["A Knowledge-Based Assessment of Dermatological Care for Transgender Women"], "prefix": "10.1089", "volume": "3", "author": [{"given": "James J.", "family": "Sabra", "sequence": "first", "affiliation": [{"name": "Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois."}]}, {"given": "Celestia X.", "family": "Fang", "sequence": "additional", "affiliation": [{"name": "Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois."}]}, {"given": "Roopal V.", "family": "Kundu", "sequence": "additional", "affiliation": [{"name": "Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois."}]}], "member": "278", "container-title": ["Transgender Health"], "language": "en", "link": [{"URL": "http://www.liebertpub.com/doi/pdf/10.1089/trgh.2018.0001", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 6, 13]], "date-time": "2018-06-13T20:03:00Z", "timestamp": 1528920180000}, "score": 21.875761, "issued": {"date-parts": [[2018, 5]]}, "references-count": 6, "journal-issue": {"published-print": {"date-parts": [[2018, 5]]}, "issue": "1"}, "alternative-id": ["10.1089/trgh.2018.0001"], "URL": "http://dx.doi.org/10.1089/trgh.2018.0001", "ISSN": ["2380-193X"], "issn-type": [{"value": "2380-193X", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 29]], "date-time": "2019-11-29T20:05:43Z", "timestamp": 1575057943556}, "reference-count": 2, "publisher": "Elsevier BV", "issue": "9296", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2001, 12, 1]], "date-time": "2001-12-01T00:00:00Z", "timestamp": 1007164800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["The Lancet"], "published-print": {"date-parts": [[2001, 12]]}, "DOI": "10.1016/s0140-6736(01)06920-3", "type": "journal-article", "created": {"date-parts": [[2002, 7, 25]], "date-time": "2002-07-25T10:04:15Z", "timestamp": 1027591455000}, "page": "1910", "source": "Crossref", "is-referenced-by-count": 5, "title": ["Oestrogen replacement therapy and ovarian cancer"], "prefix": "10.1016", "volume": "358", "author": [{"given": "Stuart V", "family": "Drew", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["The Lancet"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0140673601069203?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0140673601069203?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 7, 12]], "date-time": "2018-07-12T11:19:15Z", "timestamp": 1531394355000}, "score": 21.078083, "issued": {"date-parts": [[2001, 12]]}, "references-count": 2, "journal-issue": {"published-print": {"date-parts": [[2001, 12]]}, "issue": "9296"}, "alternative-id": ["S0140673601069203"], "URL": "http://dx.doi.org/10.1016/s0140-6736(01)06920-3", "ISSN": ["0140-6736"], "issn-type": [{"value": "0140-6736", "type": "print"}], "subject": ["General Medicine"]}, {"indexed": {"date-parts": [[2019, 11, 25]], "date-time": "2019-11-25T21:49:29Z", "timestamp": 1574718569637}, "reference-count": 0, "publisher": "Portland Press Ltd.", "issue": "2", "content-domain": {"domain": ["portlandpress.com"], "crossmark-restriction": true}, "published-print": {"date-parts": [[1982, 8, 15]]}, "abstract": "<jats:p>Tamoxifen is a potent inhibitor of specific oestrogen-induced yolk protein synthesis by chicken liver. The oestradiol receptor in salt extracts of liver nuclei from oestrogen-treated chicks has a Kd for oestradiol of 0.7\u00b10.2nm. Tamoxifen and its metabolite, monohydroxytamoxifen, compete for binding to the salt-soluble nuclear receptor with Ki values of 2.6 and 0.1nm respectively. The anti-oestrogens show much less inhibition of [3H]oestradiol binding when assays are carried out using intact nuclei. The competition by unlabelled oestradiol for [3H]oestradiol binding to receptor is identical in both salt extracts and intact nuclei. This suggests that intact nuclei contain components which bind anti-oestrogens, but not oestradiol. While tamoxifen and desmethyltamoxifen will readily dissociate from the salt-soluble nuclear oestrogen receptor, monohydroxytamoxifen does not dissociate under the conditions generally used for exchange assays. A modified assay was developed in which 60\u201370% of monohydroxytamoxifen-bound sites were shown to be exchangeable for [3H]oestradiol. Soluble receptor preparations were first incubated in a 1.7% charcoal suspension at 37\u00b0C for 15min before assay of specific oestradiol binding. This technique was used in examining the effects of tamoxifen and monohydroxytamoxifen given in vivo on the nuclear oestrogen receptor concentration. Despite their 30-fold difference in binding affinity for the receptor, both anti-oestrogens increase nuclear receptor levels to about the same degree. When given with oestradiol, both compounds have the same apparent partial inhibitory effect on the oestrogen-induced increase in nuclear receptor. These data are consistent with the metabolic hydroxylation of tamoxifen before binding to the hepatic oestrogen receptor.</jats:p>", "DOI": "10.1042/bj2060387", "type": "journal-article", "created": {"date-parts": [[2015, 8, 10]], "date-time": "2015-08-10T20:34:01Z", "timestamp": 1439238841000}, "page": "387-394", "update-policy": "http://dx.doi.org/10.1042/crossmark_policy", "source": "Crossref", "is-referenced-by-count": 10, "title": ["High affinity binding of anti-oestrogen to the chick liver nuclear oestrogen receptor"], "prefix": "10.1042", "volume": "206", "author": [{"given": "Catherine B.", "family": "Lazier", "sequence": "first", "affiliation": [{"name": "Department of Biochemistry, Dalhousie University, Halifax, Nova Scotia, Canada B3H 4H7"}]}, {"given": "V. Craig", "family": "Jordan", "sequence": "additional", "affiliation": [{"name": "Department of Human Oncology, The University of Wisconsin, Madison, WI 53792, U.S.A."}]}], "member": "288", "container-title": ["Biochemical Journal"], "language": "en", "link": [{"URL": "http://portlandpress.com/biochemj/article-pdf/206/2/387/784566/bj2060387.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "syndication"}, {"URL": "http://portlandpress.com/biochemj/article-pdf/206/2/387/784566/bj2060387.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 10, 24]], "date-time": "2019-10-24T19:27:59Z", "timestamp": 1571945279000}, "score": 21.068995, "issued": {"date-parts": [[1982, 8, 15]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1982, 8, 15]]}, "issue": "2"}, "URL": "http://dx.doi.org/10.1042/bj2060387", "ISSN": ["0306-3283"], "issn-type": [{"value": "0306-3283", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 24]], "date-time": "2019-11-24T00:13:45Z", "timestamp": 1574554425641}, "reference-count": 17, "publisher": "Elsevier BV", "issue": "5", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2014, 11, 1]], "date-time": "2014-11-01T00:00:00Z", "timestamp": 1414800000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": ["ajkd.org", "mdconsult.com", "elsevier.com", "sciencedirect.com"], "crossmark-restriction": true}, "short-container-title": ["American Journal of Kidney Diseases"], "published-print": {"date-parts": [[2014, 11]]}, "DOI": "10.1053/j.ajkd.2014.08.004", "type": "journal-article", "created": {"date-parts": [[2014, 10, 22]], "date-time": "2014-10-22T00:15:20Z", "timestamp": 1413936920000}, "page": "667-669", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "source": "Crossref", "is-referenced-by-count": 8, "title": ["Vitamin D Therapy in Kidney Disease: More Vitamin D Is Necessary"], "prefix": "10.1053", "volume": "64", "author": [{"given": "Vin", "family": "Tangpricha", "sequence": "first", "affiliation": []}, {"given": "Haimanot", "family": "Wasse", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["American Journal of Kidney Diseases"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0272638614010725?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0272638614010725?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 9, 28]], "date-time": "2018-09-28T10:27:19Z", "timestamp": 1538130439000}, "score": 20.15566, "issued": {"date-parts": [[2014, 11]]}, "references-count": 17, "journal-issue": {"published-print": {"date-parts": [[2014, 11]]}, "issue": "5"}, "alternative-id": ["S0272638614010725"], "URL": "http://dx.doi.org/10.1053/j.ajkd.2014.08.004", "ISSN": ["0272-6386"], "issn-type": [{"value": "0272-6386", "type": "print"}], "assertion": [{"value": "Elsevier", "name": "publisher", "label": "This article is maintained by"}, {"value": "Vitamin D Therapy in Kidney Disease: More Vitamin D Is Necessary", "name": "articletitle", "label": "Article Title"}, {"value": "American Journal of Kidney Diseases", "name": "journaltitle", "label": "Journal Title"}, {"value": "https://doi.org/10.1053/j.ajkd.2014.08.004", "name": "articlelink", "label": "CrossRef DOI link to publisher maintained version"}, {"value": "https://doi.org/10.1053/j.ajkd.2014.04.020", "name": "associatedlink", "label": "CrossRef DOI link to the associated document"}, {"value": "simple-article", "name": "content_type", "label": "Content Type"}, {"value": "Copyright \u00a9 2014 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.", "name": "copyright", "label": "Copyright"}]}, {"indexed": {"date-parts": [[2019, 11, 30]], "date-time": "2019-11-30T23:26:04Z", "timestamp": 1575156364351}, "reference-count": 15, "publisher": "Elsevier BV", "issue": "1", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1992, 8, 1]], "date-time": "1992-08-01T00:00:00Z", "timestamp": 712627200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Maturitas"], "published-print": {"date-parts": [[1992, 8]]}, "DOI": "10.1016/0378-5122(92)90062-9", "type": "journal-article", "created": {"date-parts": [[2005, 6, 17]], "date-time": "2005-06-17T19:36:38Z", "timestamp": 1119036998000}, "page": "53-59", "source": "Crossref", "is-referenced-by-count": 6, "title": ["Hormone replacement therapy: lipid responses to continuous combined oestrogen and progestogen versus oestrogen monotherapy"], "prefix": "10.1016", "volume": "15", "author": [{"given": "M.", "family": "Metka", "sequence": "first", "affiliation": []}, {"given": "V.", "family": "Hanes", "sequence": "additional", "affiliation": []}, {"given": "G.", "family": "Heytmanek", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Maturitas"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:0378512292900629?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:0378512292900629?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 1, 25]], "date-time": "2019-01-25T12:28:21Z", "timestamp": 1548419301000}, "score": 20.135965, "issued": {"date-parts": [[1992, 8]]}, "references-count": 15, "journal-issue": {"published-print": {"date-parts": [[1992, 8]]}, "issue": "1"}, "alternative-id": ["0378512292900629"], "URL": "http://dx.doi.org/10.1016/0378-5122(92)90062-9", "ISSN": ["0378-5122"], "issn-type": [{"value": "0378-5122", "type": "print"}], "subject": ["Obstetrics and Gynaecology", "General Biochemistry, Genetics and Molecular Biology"]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T22:14:14Z", "timestamp": 1574115254785}, "reference-count": 0, "publisher": "Bioscientifica", "issue": "1", "content-domain": {"domain": ["reproduction-online.org"], "crossmark-restriction": true}, "short-container-title": ["Reproduction"], "published-print": {"date-parts": [[1993, 1, 1]]}, "DOI": "10.1530/jrf.0.0970039", "type": "journal-article", "created": {"date-parts": [[2004, 3, 20]], "date-time": "2004-03-20T06:55:52Z", "timestamp": 1079765752000}, "page": "39-49", "update-policy": "http://dx.doi.org/10.1530/rep/crossmarkpolicy", "source": "Crossref", "is-referenced-by-count": 24, "title": ["Use of an oestrogen, androgen or gestagen as a potential chemosterilant for control of rat and mouse populations"], "prefix": "10.1530", "volume": "97", "author": [{"given": "Y.", "family": "Gao", "sequence": "first", "affiliation": []}, {"given": "R. V.", "family": "Short", "sequence": "additional", "affiliation": []}], "member": "416", "container-title": ["Reproduction"], "language": "en", "deposited": {"date-parts": [[2018, 9, 18]], "date-time": "2018-09-18T20:32:16Z", "timestamp": 1537302736000}, "score": 20.06601, "issued": {"date-parts": [[1993, 1, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1993, 1, 1]]}, "issue": "1"}, "URL": "http://dx.doi.org/10.1530/jrf.0.0970039", "ISSN": ["1470-1626", "1741-7899"], "issn-type": [{"value": "1470-1626", "type": "print"}, {"value": "1741-7899", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T04:25:31Z", "timestamp": 1574137531902}, "reference-count": 19, "publisher": "Springer Science and Business Media LLC", "issue": "6", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2002, 12, 1]], "date-time": "2002-12-01T00:00:00Z", "timestamp": 1038700800000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Breast Cancer Res"], "published-print": {"date-parts": [[2002, 12]]}, "DOI": "10.1186/bcr538", "type": "journal-article", "created": {"date-parts": [[2002, 10, 17]], "date-time": "2002-10-17T11:09:19Z", "timestamp": 1034852959000}, "source": "Crossref", "is-referenced-by-count": 2, "title": ["A new day dawns: women without oestrogen or is a balance best?"], "prefix": "10.1186", "volume": "4", "author": [{"given": "V Craig", "family": "Jordan", "sequence": "first", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2002, 12, 1]]}, "reference": [{"key": "541_CR1", "first-page": "415", "volume": "18", "author": "CW Emmens", "year": "1962", "unstructured": "Emmens CW, Cox RI, Martin L: Antiestrogens. Recent Prog Horm Res. 1962, 18: 415-466.", "journal-title": "Recent Prog Horm Res"}, {"key": "541_CR2", "doi-asserted-by": "publisher", "first-page": "1451", "DOI": "10.1016/S0140-6736(97)11423-4", "volume": "351", "author": "Early Breast Cancer Trialists' Collaborative Group", "year": "1998", "unstructured": "Early Breast Cancer Trialists' Collaborative Group: Tamoxifen for early breast cancer: an overview of the randomised trials. [see comments]. Lancet. 1998, 351: 1451-1467. 10.1016/S0140-6736(97)11423-4.", "journal-title": "Lancet"}, {"key": "541_CR3", "doi-asserted-by": "publisher", "first-page": "1371", "DOI": "10.1093/jnci/90.18.1371", "volume": "90", "author": "B Fisher", "year": "1998", "unstructured": "Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM, Vogel V, Robidoux A, Dimitrov N, Atkins J, Daly M, Wieand S, Tan-Chiu E, Ford L, Wolmark N: Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst. 1998, 90: 1371-1388. 10.1093/jnci/90.18.1371.", "journal-title": "J Natl Cancer Inst"}, {"key": "541_CR4", "doi-asserted-by": "publisher", "first-page": "56", "DOI": "10.7326/0003-4819-137-1-200207020-00016", "volume": "137", "author": "United States Preventive Services Task Force", "year": "2002", "unstructured": "United States Preventive Services Task Force: Chemoprevention of breast cancer: recommendations and rationale. Ann Intern Med. 2002, 137: 56-58.", "journal-title": "Ann Intern Med"}, {"key": "541_CR5", "doi-asserted-by": "publisher", "first-page": "2131", "DOI": "10.1016/S0140-6736(02)09088-8", "volume": "359", "author": "The ATAC (Arimidex Tamoxifen Alone or in Combination) Trialists' Group", "year": "2002", "unstructured": "The ATAC (Arimidex Tamoxifen Alone or in Combination) Trialists' Group: Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomized trial. Lancet. 2002, 359: 2131-2139. 10.1016/S0140-6736(02)09088-8.", "journal-title": "Lancet"}, {"key": "541_CR6", "doi-asserted-by": "publisher", "first-page": "16", "DOI": "10.1056/NEJM198101013040104", "volume": "304", "author": "JN Ingle", "year": "1981", "unstructured": "Ingle JN, Ahmann DL, Green SJ, Edmonson JH, Bisel HF, Kvols LK, Nichols WC, Creagan ET, Hahn RG, Rubin J, Frytak S: Randomized clinical trial of diethylstilbestrol versus tamoxifen in postmenopausal women with advanced breast cancer. N Engl J Med. 1981, 304: 16-21.", "journal-title": "N Engl J Med"}, {"key": "541_CR7", "doi-asserted-by": "publisher", "first-page": "5", "DOI": "10.1007/BF00689672", "volume": "31", "author": "AA Colletta", "year": "1994", "unstructured": "Colletta AA, Benson JR, Baum M: Alternative mechanisms of action of antioestrogens. Breast Cancer Res Treat. 1994, 31: 5-9.", "journal-title": "Breast Cancer Res Treat"}, {"key": "541_CR8", "doi-asserted-by": "publisher", "first-page": "1201", "DOI": "10.1016/S0959-8049(01)00304-5", "volume": "38", "author": "GC Wishart", "year": "2002", "unstructured": "Wishart GC, Gaston M, Poultsidis AA, Purushotham AD: Hormone receptor status in primary breast cancer \u2013 time for a consensus?. Eur J Cancer. 2002, 38: 1201-1203. 10.1016/S0959-8049(01)00304-5.", "journal-title": "Eur J Cancer"}, {"key": "541_CR9", "doi-asserted-by": "crossref", "first-page": "3808", "DOI": "10.1200/JCO.2001.19.18.3808", "volume": "19", "author": "MJ Ellis", "year": "2001", "unstructured": "Ellis MJ, Coop A, Singh B, Mauriac L, Llambert F, Cussac A, Janicke F, Miller WR, Evans DB, Dugan M, Brady C, Quebe-Fehling E, Borgs M: Letrozole is more effective neoadjuvant endocrine therapy then tamoxifen for ErbB-1 and/or ErbB-2 positive estrogen receptor positive primary breast cancer: evidence from a phase III study. J Clin Oncol. 2001, 19: 3808-3816.", "journal-title": "J Clin Oncol"}, {"key": "541_CR10", "doi-asserted-by": "publisher", "first-page": "2126", "DOI": "10.1016/S0140-6736(02)09111-0", "volume": "359", "author": "P Ravdin", "year": "2002", "unstructured": "Ravdin P: Aromatase inhibitors for the endocrine adjuvant treatment of breast cancer [editorial]. Lancet. 2002, 359: 2126-2127. 10.1016/S0140-6736(02)09111-0.", "journal-title": "Lancet"}, {"key": "541_CR11", "doi-asserted-by": "publisher", "first-page": "60", "DOI": "10.1038/scientificamerican1098-60", "volume": "279", "author": "VC Jordan", "year": "1998", "unstructured": "Jordan VC: Designer estrogens. Sci Am. 1998, 279: 60-67.", "journal-title": "Sci Am"}, {"key": "541_CR12", "first-page": "5683", "volume": "61", "author": "VC Jordan", "year": "2001", "unstructured": "Jordan VC: Selective estrogen receptor modulation: a personal perspective. Perspectives in Cancer Research. Cancer Res. 2001, 61: 5683-5687.", "journal-title": "Cancer Res"}, {"key": "541_CR13", "doi-asserted-by": "publisher", "first-page": "2189", "DOI": "10.1001/jama.281.23.2189", "volume": "281", "author": "SR Cummings", "year": "1999", "unstructured": "Cummings SR, Eckert S, Krueger KA, Grady D, Powles TJ, Cauley JA, Norton L, Nickelsen T, Bjarnason NH, Morrow M, Lippman ME, Black D, Glusman JE, Costa A, Jordan VC: The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation. JAMA. 1999, 281: 2189-2197. 10.1001/jama.281.23.2189.", "journal-title": "JAMA"}, {"key": "541_CR14", "doi-asserted-by": "publisher", "first-page": "9", "DOI": "10.1200/JCO.20.1.9", "volume": "20", "author": "D Hershman", "year": "2002", "unstructured": "Hershman D, Sundararajan V, Jacobson JS, Heitjan DF, Neugut AI, Grann VR: Outcomes of tamoxifen for breast cancer in very high risk women: a cost effectivness analysis. J Clin Oncol. 2002, 20: 9-16. 10.1200/JCO.20.1.9.", "journal-title": "J Clin Oncol"}, {"key": "541_CR15", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1200/JCO.2002.20.1.1", "volume": "20", "author": "VC Jordan", "year": "2002", "unstructured": "Jordan VC, Morrow MM: Chemoprevention of breast cancer: a model for change. J Clin Oncol. 2002, 20: 1-2.", "journal-title": "J Clin Oncol"}, {"key": "541_CR16", "doi-asserted-by": "publisher", "first-page": "331", "DOI": "10.1136/bmj.319.7206.331", "volume": "319", "author": "VC Jordan", "year": "1999", "unstructured": "Jordan VC, Morrow M: Raloxifene as a multifunctional medicine?. BMJ. 1999, 319: 331-332.", "journal-title": "BMJ"}, {"key": "541_CR17", "first-page": "4177", "volume": "50", "author": "LJ Lerner", "year": "1990", "unstructured": "Lerner LJ, Jordan VC: The development of antiestrogens for the treatment of breast cancer. Cancer Res. 1990, 50: 4177-4189.", "journal-title": "Cancer Res"}, {"key": "541_CR18", "doi-asserted-by": "publisher", "first-page": "1449", "DOI": "10.1093/jnci/93.19.1449", "volume": "93", "author": "VC Jordan", "year": "2001", "unstructured": "Jordan VC, Gapstur S, Morrow M: Selective estrogen receptor modulation to reduce breast cancer risk, osteoporosis and coronary heart disease. J Natl Cancer Inst. 2001, 93: 1449-1457. 10.1093/jnci/93.19.1449.", "journal-title": "J Natl Cancer Inst"}, {"key": "541_CR19", "author": "VC Jordan", "year": "2002", "unstructured": "Jordan VC: Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. J Med Chem. 2002,", "volume-title": "J Med Chem"}], "container-title": ["Breast Cancer Research"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1186/bcr538.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1186/bcr538/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1186/bcr538.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 1, 7]], "date-time": "2018-01-07T18:59:38Z", "timestamp": 1515351578000}, "score": 20.054243, "issued": {"date-parts": [[2002, 12]]}, "references-count": 19, "journal-issue": {"published-print": {"date-parts": [[2002, 12]]}, "issue": "6"}, "alternative-id": ["541"], "URL": "http://dx.doi.org/10.1186/bcr538", "relation": {"cites": []}, "ISSN": ["1465-542X"], "issn-type": [{"value": "1465-542X", "type": "electronic"}], "article-number": "218"}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}